NCT06425237 Evaluation of the Influence of Aromatherapy and Music Therapy on Stress During the Management of Cerebral Arteriography
| NCT ID | NCT06425237 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Rouen |
| Condition | Patients Scheduled for Cerebral Arteriography for Diagnostic or Therapeutic Purposes |
| Study Type | INTERVENTIONAL |
| Enrollment | 224 participants |
| Start Date | 2024-11-04 |
| Primary Completion | 2027-11-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 224 participants in total. It began in 2024-11-04 with a primary completion date of 2027-11-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cerebral arteriography is a reference examination in medical imaging. This examination is performed to allow the diagnosis and therapeutic management of patients with vascular pathologies. It is most often accompanied by a situation of stress, anxiety and apprehension related to the course of the examination or the announcement of the results. These situations generate physiological reactions in patients, making the performance of cerebral arteriography more complex. In order to improve the quality of care for patients undergoing this invasive examination, it is proposed to use two non-medicinal techniques known for their soothing and relaxing properties: aromatherapy and music therapy alone or in combination. These two techniques will help to establish a common thread from the preparation of the patient before the examination to his return to the post-interventional surveillance room.
Eligibility Criteria
Inclusion Criteria: * Adult (≥ 18 years old) * Patient who is scheduled for a cerebral arteriography with local anaesthesia * Patient who capable to read and understand the patient information and consent. * Patient capable to read and sign the consent form * Patient with social insurance * Woman of childbearing age with effective contraception (see WHO definition), postmenopausal woman (≥ 12 months of amenorrhea not induced by therapy) * Negative urine pregnancy test Exclusion Criteria: * Patients who have had a previous cerebral arteriogram * Patient with allergy to iodinated contrast medium * Patient with severe renal insufficiency * Patient requiring sedation and artificial ventilation * Patient who is deaf and/or hard of hearing * Patient with a known allergy to essential oils * Patient with anosmia * Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection, under guardianship or curatorship, * Pregnant or breastfeeding woman
Contact & Investigator
Magali DUVAL, radiology technician
PRINCIPAL INVESTIGATOR
CHU Rouen
Frequently Asked Questions
Who can join the NCT06425237 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Patients Scheduled for Cerebral Arteriography for Diagnostic or Therapeutic Purposes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06425237 currently recruiting?
Yes, NCT06425237 is actively recruiting participants. Contact the research team at magali.duval@chu-rouen.fr for enrollment information.
Where is the NCT06425237 trial being conducted?
This trial is being conducted at Rouen, France.
Who is sponsoring the NCT06425237 clinical trial?
NCT06425237 is sponsored by University Hospital, Rouen. The principal investigator is Magali DUVAL, radiology technician at CHU Rouen. The trial plans to enroll 224 participants.